世界の生検装置市場予測　2024-2032年

Inkwood Researchでは世界の主要地域・国別の市場調査レポートも出版しています。各レポートの詳細についてはお問合せください。

• アジア太平洋地域の生検装置市場予測　2024-2032年
  ASIA-PACIFIC BIOPSY DEVICES MARKET FORECAST 2024-2032
• 欧州の生検装置市場予測　2024-2032年
  EUROPE BIOPSY DEVICES MARKET FORECAST 2024-2032
• 北米の生検装置市場予測　2024-2032年
  NORTH AMERICA BIOPSY DEVICES MARKET FORECAST 2024-2032 
• フランスの生検装置市場予測　2024-2032年
  FRANCE BIOPSY DEVICES MARKET FORECAST 2024-2032
• ドイツの生検装置市場予測　2024-2032年
  GERMANY BIOPSY DEVICES MARKET FORECAST 2024-2032
• 米国の生検装置市場予測　2024-2032年
  UNITED STATES BIOPSY DEVICES MARKET FORECAST 2024-2032

Report Overview

KEY FINDINGS
The global biopsy devices market is estimated to prosper at a CAGR of 7.23% over the forecast period of 2024-2032. The market growth is elevated by several factors, including the rising prevalence of cancer, increasing demand for minimally invasive surgeries, and a surge in the number of hospitals and diagnostic centers.

MARKET INSIGHTS
The global biopsy devices market is witnessing substantial growth, escalated by advancements in healthcare technology and a rising emphasis on early disease detection. Biopsy devices are vital in obtaining tissue samples for diagnostic purposes, aiding in the identification and characterization of various medical conditions, particularly cancer. The increasing prevalence of cancer and other chronic diseases, combined with a growing aging population, has resulted in a significant rise in demand for biopsy procedures globally.
The market encompasses a diverse range of biopsy devices, including needle-based instruments, core biopsy devices, and vacuum-assisted biopsy systems. Furthermore, technological innovations, such as minimally invasive biopsy techniques and advanced imaging guidance systems, contribute significantly to the market’s ongoing expansion. The integration of modern technologies marks the evolving sphere to ensure more precise and efficient biopsy procedures.
Government initiatives supporting cancer screening programs, along with advancements like the integration of artificial intelligence in diagnostics, serve as additional growth enablers for the market. Continuous research and technological developments are expected to shape the future of this crucial healthcare sector, strengthening its role in providing essential diagnostic solutions in the ever-changing biopsy devices domain.

REGIONAL INSIGHTS
The global biopsy devices market growth analysis is conducted based on the geographical segmentation of North America, Europe, Asia-Pacific, and Rest of World. North America is expected to be the eminent region in the global market, attributed to the ongoing expansion and increased investment in advanced infrastructure. Moreover, the upward course of healthcare expenditure is driving the adoption of biopsy devices, with the goal of enhancing disease detection and ultimately improving patient outcomes.

REPORT SYNOPSIS

COMPETITIVE INSIGHTS
The global biopsy devices market industry rivalry is fiercely competitive, powered by companies striving for distinction through branding and technology. The relentless pursuit of innovation and market leadership shapes the strong domain of biopsy devices. Some of the major companies in the global biopsy devices market include INRAD Inc, DTR Medical, Cardinal Health, Boston Scientific, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

1. RESEARCH SCOPE & METHODOLOGY
   1.1. STUDY OBJECTIVES
   1.2. METHODOLOGY
   1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
   2.1. MARKET SIZE & ESTIMATES
   2.2. MARKET OVERVIEW
   2.3. SCOPE OF STUDY
   2.4. CRISIS SCENARIO ANALYSIS
   2.4.1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
   2.5. MAJOR MARKET FINDINGS
   2.5.1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
   2.5.2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
   2.5.3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS
3. MARKET DYNAMICS
   3.1. KEY DRIVERS
   3.1.1. RISING PREVALENCE OF CANCER
   3.1.2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
   3.1.3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
   3.2. KEY RESTRAINTS
   3.2.1. HIGH RISK OF INFECTION FOR PATIENTS
   3.2.2. HIGH COST OF BIOPSY PROCEDURES
   3.2.3. LACK OF SKILLED PROFESSIONALS
4. KEY ANALYTICS
   4.1. KEY MARKET TRENDS
   4.1.1. SURGE IN THE HEALTHCARE EXPENDITURE
   4.1.2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
   4.1.3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
   4.2. PORTER’S FIVE FORCES ANALYSIS
   4.2.1. BUYERS POWER
   4.2.2. SUPPLIERS POWER
   4.2.3. SUBSTITUTIONS
   4.2.4. NEW ENTRANTS
   4.2.5. INDUSTRY RIVALRY
   4.3. GROWTH PROSPECT MAPPING
   4.4. MARKET MATURITY ANALYSIS
   4.5. MARKET CONCENTRATION ANALYSIS
   4.6. VALUE CHAIN ANALYSIS
   4.6.1. RAW MATERIALS
   4.6.2. MANUFACTURERS
   4.6.3. DISTRIBUTION
   4.6.4. END-USERS
5. MARKET BY PRODUCT
   5.1. NEEDLE- BASED BIOPSY GUNS
   5.1.1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
   5.1.2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
   5.1.3. CORE NEEDLE BIOPSY (CNB) DEVICES
   5.2. BIOPSY GUIDANCE SYSTEMS
   5.3. BIOPSY NEEDLES
   5.4. BIOPSY FORCEPS
   5.5. OTHER PRODUCTS
6. MARKET BY APPLICATION
   6.1. ONCOLOGY
   6.2. GASTROENTEROLOGY
   6.3. PULMONOLOGY
   6.4. DERMATOLOGY
   6.5. OTHER APPLICATIONS
7. MARKET BY END USE
   7.1. HOSPITALS
   7.2. AMBULATORY SURGICAL CENTERS
   7.3. DIAGNOSTIC CENTERS
8. GEOGRAPHICAL ANALYSIS
   8.1. GLOBAL
   8.1.1. MARKET SIZE & ESTIMATES
   8.1.2. GLOBAL BIOPSY DEVICES MARKET DRIVERS
   8.1.3. GLOBAL BIOPSY DEVICES MARKET CHALLENGES
   8.1.4. KEY PLAYERS IN GLOBAL BIOPSY DEVICES MARKET
   8.1.5. COUNTRY ANALYSIS
   8.1.5.1. UNITED STATES
   8.1.5.2. CANADA
   8.2. EUROPE
   8.2.1. MARKET SIZE & ESTIMATES
   8.2.2. EUROPE BIOPSY DEVICES MARKET DRIVERS
   8.2.3. EUROPE BIOPSY DEVICES MARKET CHALLENGES
   8.2.4. KEY PLAYERS IN EUROPE BIOPSY DEVICES MARKET
   8.2.5. COUNTRY ANALYSIS
   8.2.5.1. UNITED KINGDOM
   8.2.5.2. GERMANY
   8.2.5.3. FRANCE
   8.2.5.4. ITALY
   8.2.5.5. SPAIN
   8.2.5.6. POLAND
   8.2.5.7. BELGIUM
   8.2.5.8. DENMARK
   8.2.5.9. REST OF EUROPE
   8.3. ASIA-PACIFIC
   8.3.1. MARKET SIZE & ESTIMATES
   8.3.2. ASIA-PACIFIC BIOPSY DEVICES MARKET DRIVERS
   8.3.3. ASIA-PACIFIC BIOPSY DEVICES MARKET CHALLENGES
   8.3.4. KEY PLAYERS IN ASIA-PACIFIC BIOPSY DEVICES MARKET
   8.3.5. COUNTRY ANALYSIS
   8.3.5.1. CHINA
   8.3.5.2. JAPAN
   8.3.5.3. INDIA
   8.3.5.4. SOUTH KOREA
   8.3.5.5. TAIWAN
   8.3.5.6. SINGAPORE
   8.3.5.7. AUSTRALIA & NEW ZEALAND
   8.3.5.8. REST OF ASIA-PACIFIC
   8.4. REST OF WORLD
   8.4.1. MARKET SIZE & ESTIMATES
   8.4.2. REST OF WORLD BIOPSY DEVICES MARKET DRIVERS
   8.4.3. REST OF WORLD BIOPSY DEVICES MARKET CHALLENGES
   8.4.4. KEY PLAYERS IN REST OF WORLD BIOPSY DEVICES MARKET
   8.4.5. REGIONAL ANALYSIS
   8.4.5.1. LATIN AMERICA
   8.4.5.2. MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
   9.1. KEY STRATEGIC DEVELOPMENTS
   9.1.1. MERGERS & ACQUISITIONS
   9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
   9.1.3. PARTNERSHIPS & AGREEMENTS
   9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
   9.2. COMPANY PROFILES
   9.2.1. CARDINAL HEALTH
   9.2.2. HOLOGIC INC
   9.2.3. DANAHER CORPORATION
   9.2.4. CONMED CORPORATION
   9.2.5. COOK MEDICAL
   9.2.6. DTR MEDICAL
   9.2.7. INRAD INC
   9.2.8. BOSTON SCIENTIFIC
   9.2.9. MEDTRONIC PLC
   9.2.10. BECTON DICKINSON AND COMPANY
   9.2.11. MAMMOTOME
   9.2.12. ARGON MEDICAL DEVICES

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – BIOPSY DEVICES
TABLE 2: GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: GLOBAL NEEDLE-BASED BIOPSY GUNS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL NEEDLE-BASED BIOPSY GUNS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: GLOBAL BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL VACUUM-ASSISTED BIOPSY (VAB) DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL VACUUM-ASSISTED BIOPSY (VAB) DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: GLOBAL CORE NEEDLE BIOPSY (CNB) DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL CORE NEEDLE BIOPSY (CNB) DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: GLOBAL BIOPSY GUIDANCE SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL BIOPSY GUIDANCE SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: GLOBAL BIOPSY NEEDLES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL BIOPSY NEEDLES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: GLOBAL BIOPSY FORCEPS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL BIOPSY FORCEPS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 20: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 22: GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 24: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 26: GLOBAL GASTROENTEROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL GASTROENTEROLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 28: GLOBAL PULMONOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: GLOBAL PULMONOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 30: GLOBAL DERMATOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 31: GLOBAL DERMATOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 32: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 34: GLOBAL BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 35: GLOBAL BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 36: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 37: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 38: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 39: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 40: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 41: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 42: GLOBAL BIOPSY DEVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 43: GLOBAL BIOPSY DEVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 44: GLOBAL BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 45: GLOBAL BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 46: KEY PLAYERS OPERATING IN GLOBAL BIOPSY DEVICES MARKET
TABLE 47: EUROPE BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 48: EUROPE BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 49: KEY PLAYERS OPERATING IN EUROPE BIOPSY DEVICES MARKET
TABLE 50: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 51: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 52: KEY PLAYERS OPERATING IN ASIA-PACIFIC BIOPSY DEVICES MARKET
TABLE 53: REST OF WORLD BIOPSY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 54: REST OF WORLD BIOPSY DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 55: KEY PLAYERS OPERATING IN REST OF WORLD BIOPSY DEVICES MARKET
TABLE 56: LIST OF MERGERS & ACQUISITIONS
TABLE 57: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 58: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 59: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: GLOBAL BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 8: GLOBAL BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, 2024-2032 (IN $ MILLION)
FIGURE 9: GLOBAL BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY NEEDLE-BASED BIOPSY GUNS, IN 2023
FIGURE 10: GLOBAL BIOPSY DEVICES MARKET, BY VACUUM-ASSISTED BIOPSY (VAB) DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 11: GLOBAL BIOPSY DEVICES MARKET, BY FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 12: GLOBAL BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY (CNB) DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 13: GLOBAL BIOPSY DEVICES MARKET, BY BIOPSY GUIDANCE SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 14: GLOBAL BIOPSY DEVICES MARKET, BY BIOPSY NEEDLES, 2024-2032 (IN $ MILLION)
FIGURE 15: GLOBAL BIOPSY DEVICES MARKET, BY BIOPSY FORCEPS, 2024-2032 (IN $ MILLION)
FIGURE 16: GLOBAL BIOPSY DEVICES MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 17: GLOBAL BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023
FIGURE 18: GLOBAL BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 19: GLOBAL BIOPSY DEVICES MARKET, BY GASTROENTEROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 20: GLOBAL BIOPSY DEVICES MARKET, BY PULMONOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 21: GLOBAL BIOPSY DEVICES MARKET, BY DERMATOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 22: GLOBAL BIOPSY DEVICES MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)
FIGURE 23: GLOBAL BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY END USE, IN 2023
FIGURE 24: GLOBAL BIOPSY DEVICES MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 25: GLOBAL BIOPSY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 26: GLOBAL BIOPSY DEVICES MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 27: GLOBAL BIOPSY DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 28: UNITED STATES BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 29: CANADA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 30: EUROPE BIOPSY DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 31: UNITED KINGDOM BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 32: GERMANY BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 33: FRANCE BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 34: ITALY BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 35: SPAIN BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 36: POLAND BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 37: BELGIUM BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 38: DENMARK BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 39: REST OF EUROPE BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC BIOPSY DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 41: CHINA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 42: JAPAN BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 43: INDIA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 44: SOUTH KOREA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 45: TAIWAN BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 46: SINGAPORE BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 47: AUSTRALIA & NEW ZEALAND BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 48: REST OF ASIA-PACIFIC BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 49: REST OF WORLD BIOPSY DEVICES MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)
FIGURE 50: LATIN AMERICA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)
FIGURE 51: MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)